POSTER SESSION VI
Wednesday, February 15, 2006   —  1:00 - 4:00 PM
Exhibit Level


BONE & SOFT TISSUE



1 Cytogenetic Aberrations in Mesenchymal Neoplasms: A Single Institutional Experience (54)
AL Matthews, M Tang, K Cooper - University of Vermont, Burlington, VT
2 Promoter Methylation Profiling Of Tumor Suppressor Genes In Pleomorphic Sarcoma (65)
A Roma, L Wang, R Patel, E Downs-Kelly, T Jin, J Goldblum, B Yang - Cleveland Clinic Foundation, Cleveland, OH; Emory University, Atlanta, GA
3 CTSP-1, A New Cancer-Testis Antigen Are Expressed in Sarcomas, but Not in Benign Mesenchymal Tumors (29)
IW Cunha, RB Parmigiani, LDC Mota, DM Carraro, LFL Reis, FA Soares, AA Camargo - Hospital do Câncer, Sno Paulo, Brazil; Ludwig Institute, Sno Paulo, Brazil
4 Heat-Shock Protein-90 (HSP-90) Expression In A Spectrum Of Benign And Malignant Spindle Cell Neoplasms: An Immunohistochemical Study (47)
AJ Larson, E Downs-Kelley, M Skacel, TO Nielsen, C Ruttan, M van de Rijn, RB West, BP Rubin, C Corless, JR Goldblum - The Cleveland Clinic Foundation, Cleveland, OH; University of BC, Vancouver, BC, Canada; Stanford University, Stanford, CA; University of Washington, Seattle, WA; Oregon Health & Science University, Portland, OR
5 Epidermal Growth Factor Receptor (EGFR) Expression And Gene Amplification In A Spectrum Of Spindle Cell Soft Tissue Neoplasms: A Fluorescence In Situ Hybridization (FISH) And Immunohistochemical (IHC) Study (48)
AJ Larson, E Downs-Kelley, M Skacel, RR Tubbs, BP Rubin, M van de Rijn, RB West, C Corless, A Chiesa, JR Goldblum - The Cleveland Clinic Foundation, Cleveland, OH; University of Washington, Seattle, WA; Stanford University, Stanford, CA; Oregon Health & Science University, Portland, OR
6 Analysis of ALK Abnormalities in Inflammatory Myofibroblastic Tumors: An Immunohistochemical (IHC) and Fluorescence In Situ Hybridization (FISH) Study (61)
B Papouchado, ED Kelley, M Skacel, JR Goldblum - Cleveland Clinic Foundation, Cleveland, OH
7 GLUT-1 Expression And Enhanced Glucose Metabolism Are Associated With Tumor Grade In Bone And Soft Tissue Sarcomas: A Prospective Evaluation By [F-18]-Fluorodeoxyglucose Positoron Emission Tomography (70)
K Seki, U Tateishi, U Yamaguchi, T Hasegawa - National Cancer Center Hospital, Tokyo, Japan; Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
8 Can Immunohistochemistry for Human Telomerase Reverse Transcriptase Catalytic Subunit (hTERT) Distinguish Benign from Malignant Soft Tissue and Bone Tumors? (62)
RM Patel, AL Folpe - Emory University, Atlanta, GA
9 Prognostic Indicators In Cutaneous Angiosarcoma: Are There Any? (33)
AT Deyrup, JK McKenney, M Tighiouart, AL Folpe, SW Weiss - Emory University, Atlanta, GA; University of Arkansas, Little Rock, AR
10 Sporadic Vs Radiation-Associated Angiosarcoma: Biologic And Clinicopathologic Comparisons (55)
JB McHugh, DG Thomas, JM Herman, ME Ray, LH Baker, DR Lucas - University of Michigan, Ann Arbor, MI
11 Malignant Vascular Tumors of Bone: A Clinicopathologic and Radiographic Study of 78 Cases (22)
F Bertoni, C Inwards, P Bacchini, D Mellano - Rizzoli Institute, Bologna, Italy; Mayo Clinic, Rochester, MN
12 Composite Hemangioendothelioma (CHE): Report Of Five Cases Including Congenital Lesions (40)
M Fukunaga - Jikei University Daisan Hospital, Komaeshi, Tokyo, Japan
13 CDK4 Amplification In Central Chondrosarcoma Is Associated With Tumor Progression (69)
YM Schrage, K Szuhai, AHM Taminiau, PCW Hogendoorn, JVMG Bovée - Leiden University Medical Center, Leiden, Netherlands
14 A Differentially Expressed Gene-Set Differentiates Chondromyxoid Fibroma From High-Grade Central Chondrosarcoma (67)
S Romeo, L Hameetman, J Oosting, LB Rozeman, AM Cleton-Jansen, JVMG Bovée, PCW Hogendoorn - Leiden University Medical Center, Leiden, Netherlands
15 Intraosseous Benign Notochord Cell Tumors (BNCT): Further Evidence Supporting A Relationship To Chordoma (31)
V Deshpande, GP Nielsen, HJ Mankin, AE Rosenberg - Massachusetts General Hospital, Boston, MA
16 D2-40 as a Novel Chondroid Marker Differentiating True Chondroid Tumors from Chordomas (44)
JT Huse, TL Pasha, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
17 Immunohistochemical Expression of Estrogen Receptors in Chondroid Neoplasms (43)
TJ Grifone, HM Haupt, V Podolski, JS Brooks - Pennsylvania Hospital, Philadelphia, PA
18 Array-CGH Analysis of Chondromyxoid Fibroma (66)
S Romeo, K Szuhai, J Oosting, PCW Hogendoorn - Leiden University Medical Center, Leiden, Netherlands
19 Histologic Response to Neoadjuvant Chemotherapy: A Poor Predictor of Outcome in High Grade Extremity Soft Tissue Sarcomas (46)
MP Kshirsagar, LH Baker, JS Biermann, DR Lucas - The University of Michigan, Ann Arbor, MI
20 Multidrug Resistance Activity In Human Osteosarcoma Cell Lines And Reversal Of Chemosensitivity (42)
CM Gomes, HJ Van Paassen, MM Welling, RJ Feitsma, AJ Abrunhosa, MF Botelho, PC Hogendoorn, EK Pauwels, AM Cleton-Jansen - Leiden University Medical Center, Leiden, Netherlands; University of Coimbra, Coimbra, Portugal
21 Sarcomas Arising In Paget Disease Of Bone, Still Bad After All These Years: A Clinicopathologic Analysis Of 68 Cases (32)
AT Deyrup, AG Montag, KK Unni - Emory University, Atlanta, GA; University of Chicago, Chicago, IL; The Mayo Clinic, Rochester, MN
22 Telomerase Expression In Giant Cell Tumor (GCT) Of Bone (41)
J Garcia, MJ Kramer, R O'Donnell, AE Horvai - University of California, San Francisco, CA
23 Tumoral Calcinosis-Like Lesions Of The Distal Extremities (49)
WB Laskin, M Miettinen, JF Fetsch - Feinberg School of Medicine, Northwestern University, Chicago, IL; Armed Forces Institute of Pathology, Washington, DC
24 Frequency of USP6 Locus Rearrangements in Myositis Ossificans, Brown Tumors and Cherubism (72)
WR Sukov, M Erickson-Johnson, MM Chou, KK Unni, AM Oliveira - Mayo Clinic, Rochester, MN; University of Pennsylvania School of Medicine, Philadelphia, PA